Results 61 to 70 of about 104,921 (341)

Clinical significance of the buccal fat pad: how to determine the correct surgical indications based on preoperative analysis [PDF]

open access: yes, 2018
Background: Despite the multitude of clinical and aesthetic uses, the correct surgical indications for buccal fat pad (BFP) removal have yet to be fully elucidated.
Bencardino, Davide   +6 more
core   +1 more source

Unilateral Upper Limb Lymphedema After Microwave Thermolysis Treatment for Axillary Hyperhidrosis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Microwave thermolysis (MiraDry) is an approved, nonsurgical treatment for axillary hyperhidrosis. We report a case of unilateral lymphedema of the upper limb in a 45‐year‐old male patient treated for axillary hyperhidrosis with the MiraDry device.
Emanuela Micu, Natalja Jacobsson
wiley   +1 more source

Vasculitis with panniculitis following botulinum toxin A injection for cosmetic use

open access: yesDermatology Practical & Conceptual, 2016
Botulinum toxin A injection is performed most frequently for facial rejuvenation all over the world. Some bizarre and severe side effects have been reported after botulinum toxin A injection.
Nastaran Namazi   +4 more
doaj   +1 more source

A pragmatic harm reduction approach to manage a large outbreak of wound botulism in people who inject drugs, Scotland 2015 [PDF]

open access: yes, 2018
Background People who inject drugs (PWID) are at an increased risk of wound botulism, a potentially fatal acute paralytic illness. During the first 6 months of 2015, a large outbreak of wound botulism was confirmed among PWID in Scotland, which resulted ...
Amanda Weir   +43 more
core   +1 more source

Adjunctive Botulinum Toxin Type A for Bruxism and Sweat‐Worsened Facial Blistering in Recessive Dystrophic Epidermolysis Bullosa: A Case Series

open access: yesJEADV Clinical Practice, EarlyView.
Capsule Summary Bruxism and sweat‐induced facial blisters can affect patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) quality of life (QoL). We present the outcomes of orofacial BTX‐A infiltrations to treat these conditions. Three patients with severe RDEB, bruxism and microstomia received BTX‐A infiltrations (50U‐100U) in masseters and ...
Susanne Krämer   +4 more
wiley   +1 more source

Botulinum toxin application to the buccinator muscle in the treatment of facial synkinesis: a prospective cohort study

open access: yesAustralasian Journal of Plastic Surgery
**Background**: Synkinesis may develop following facial nerve palsy, impacting quality of life. Botulinum toxin treatment for synkinesis is commonly used, but buccinator muscle injection is less common.
Raymond Hayler   +4 more
doaj   +1 more source

Treatment Efficacy of Electromyography versus Fiberscopy-Guided Botulinum Toxin Injection in Adductor Spasmodic Dysphonia Patients: A Prospective Comparative Study

open access: yesThe Scientific World Journal, 2014
Introduction. This study prospectively evaluates and compares the treatment efficacy of botulinum toxin injection under electromyography guidance (EMG group) and percutaneous botulinum toxin injection under flexible fiberscopic guidance (fiberscopy group)
Jae Wook Kim   +3 more
doaj   +1 more source

Botulinum Toxin in the Treatment of Lingual Dystonia Induced by Speaking

open access: yesCase Reports in Neurology, 2013
Primary lingual dystonia is a rare condition, especially when it is only induced by speaking. Trihexyphenidyl failed to improve the symptoms. Several case series have demonstrated the effectiveness of botulinum toxin injection for the management of focal
F. Budak   +3 more
doaj   +1 more source

Botulinum toxin type A for Holmes tremor secondary to thalamic hemorrhage [PDF]

open access: yes, 2015
Holmes tremor (HT) is a low-frequency rest and intentional tremor frequently affecting the upper limb.
Giovannelli, Morena   +3 more
core   +1 more source

Botulinum toxin and spasticity [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2000
The clinical effects of botulinum toxin have been recognised since the end of the 19th century. It is the most potent neurotoxin known and it is produced by the gram negative anaerobic bacterium Clostridium botulinum. The paralytic effect of the toxin is due to blockade of neuromuscular transmission.1 Injection into a muscle causes chemodenervation and
E C, Davis, M P, Barnes
openaire   +2 more sources

Home - About - Disclaimer - Privacy